Adipokines promote chronic kidney disease

Area of Science:

• Endocrinology
• Nephrology
• Metabolic Disorders

Background:

• Global obesity rates are rising, leading to increased metabolic syndrome and obesity-related kidney disease.
• Adipose tissue functions as an endocrine organ, releasing factors implicated in renal and cardiovascular complications.
• Obesity-related factors contribute to chronic kidney disease progression, potentially reaching end-stage renal disease.

Purpose of the Study:

• To explore the role of adipokines in obesity-induced renal damage.
• To understand how obesity disrupts the balance of protective and detrimental adipokines.
• To highlight the importance of weight management in mitigating kidney disease risk.

Main Methods:

• Review of current literature on obesity, adipokines, and kidney disease.
• Analysis of the mechanisms by which adipokines influence renal function.
• Examination of the interplay between adipokines, metabolic syndrome components, and renal pathology.

Main Results:

• Adipokines mediate renal damage via endothelial dysfunction, oxidative stress, inflammation, and altered bone metabolism.
• Obesity disrupts the balance between protective adiponectin and detrimental factors like angiotensin II and TNFα.
• This imbalance contributes to the development of renal anemia and progression of kidney disease.

Conclusions:

• Obesity-induced disruption of adipokine balance is a key driver of kidney disease.
• Weight reduction and lifestyle modifications are essential to reverse this process.
• Targeting metabolic syndrome components can help prevent and manage obesity-related renal complications.